Evolución de los síntomas del TDAH y problemas asociadosefectos del tratamiento farmacológico
- Ana Miranda Casas
- Mª Inmaculada Fernández Andrés
- Belén Roselló Mirand
- Carla Colomer Diago
ISSN: 0214-9877
Argitalpen urtea: 2012
Zenbakien izenburua: PSICOLOGÍA Y VALORES EN EL MUNDO ACTUAL
Alea: 3
Zenbakia: 1
Orrialdeak: 93-103
Mota: Artikulua
Beste argitalpen batzuk: International Journal of Developmental and Educational Psychology: INFAD. Revista de Psicología
Laburpena
The aim of this research was to analyze the effects of psychostimulant treatment on the severity of ADHD symptoms and associated problems. Method. 65 children with ADHD were classified into three groups according to their medication history: Group-1: ADHD-MP (long-term medication, N=23), under medication for at least three years; Group-2: ADHD-MB (short medication, N=20), under medication for less than three years and Group-3: ADHD-SM (without medication, N=22). In time 1 and time 2 (follow-up) parents filled out the Conners rating scale. Results. Generally, inattention, hyperactivity and impulsivity symptoms and behavioral problems decreased in the follow-up. Anxiety was the only variable that showed a significant increase over time. Moreover, the ADHD-MP group showed significantly higher scores than ADHD-SM group on variables related to ADHD symptoms. There were no interaction effects of Time x Medication. Conclusions. The results suggest the need for more complex analysis to assess the long-term response to medication in the treatment of ADHD.